In our cohort, however, IL-2, TNF-α and IL-18 concentrations did not show significant associations with disease course, and none of these analytes showed a pattern that would plausibly help to distinguish immune-mediated demyelinating neuropathy from diabetes-associated neuropathy, which is an important finding given the persistent diagnostic uncertainty in this area. The gene discussed is IL2; the disease is neuropathy.